Source: Yahoo
Baveno
Intellia Therapeutics to Present Longer-Term
Intellia Therapeutics to Present Longer-Term Data from the Ongoing Phase 1 Clinical Trial of Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy Intellia Therapeutics
Posted on 22 September 2025 | 4:30 am
Weather tracker: deep trough over Europe
Weather tracker: deep trough over Europe brings severe storms | Italy The Guardian
Posted on 1 September 2025 | 12:00 am
Half of Italy is gripped by bad weather: in
Half of Italy is gripped by bad weather: in the north, storms are sweeping away summer, and the alert is on. L'Unione Sarda.it
Posted on 28 August 2025 | 11:56 pm
Intellia Therapeutics Announces Second
Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress Intellia Therapeutics
Posted on 7 August 2025 | 12:00 am
A Combined Model of Spleen Stiffness and
A Combined Model of Spleen Stiffness and Baveno VII Criteria for Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease: An International Multicenter Study Wiley Online Library
Posted on 10 March 2025 | 12:00 am